Skip to main content
Live · TradingView
Back to the NewsWire

Stocktitan

Published September 14, 2026 · Updated September 15, 2026

Rhelion Filament to Deliver Oral Comments at FDA Hearing | TRUFF Stock News

Read the full story at Stocktitan

PDS Biotech Announces Initial Closing of up to $22.3 Million PIPE... ... Psychedelic Drugs. Rhelion's subsidiary Filament will speak at an FDA.

Surfaced by this Google Alert

  • Psychedelic biotech